Taysha Gene Therapies Inc (TSHA)

Financing Cash Flow

$275.72M

TTM · Period ending: · USD

TSHA logo

TSHA Financing Cash Flow

Latest reported$275.72M
TSHA TTM Cash from Financing ($292.55M → $275.72M)
High-resolution chart · PNG

TSHA financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Taysha Gene Therapies Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
275,719,000
275,352,000
274,589,000
224,676,000
222,474,000
76,654,000
76,684,000
72,793,000
206,832,000
136,741,000
136,393,000
182,308,000
41,571,000
52,269,000
52,532,000
19,970,000
50,051,000
38,976,000
39,083,000
28,496,000
272,699,000
273,037,000
291,064,000
292,546,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.